Cleared Traditional

K211085 - BD Perisafe Tuohy Epidural Needle

K211085 is the FDA 510(k) clearance for BD Perisafe Tuohy Epidural Needle by Becton, Dickinson and Company. It is a Class 2 Anesthesiology device (product code BSP) cleared through the Traditional 510(k) pathway after a 445-day FDA review.

K211085 · Becton, Dickinson and Company · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
445d
Days
Class 2
Risk

K211085 is an FDA 510(k) clearance for the BD Perisafe Tuohy Epidural Needle, BD Perisafe Weiss Epidural Needle. Classified as Needle, Conduction, Anesthetic (w/wo Introducer) (product code BSP), Class II - Special Controls.

Submitted by Becton, Dickinson and Company (Franklin Lakes, US). The FDA issued a Cleared decision on July 1, 2022 after a review of 445 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5150 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Becton, Dickinson and Company devices

Submission Details

510(k) Number K211085 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2021
Decision Date July 01, 2022
Days to Decision 445 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
305d slower than avg
Panel avg: 140d · This submission: 445d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BSP Needle, Conduction, Anesthetic (w/wo Introducer)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5150
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BSP Needle, Conduction, Anesthetic (w/wo Introducer)

All 64
Devices cleared under the same product code (BSP) and FDA review panel - the closest regulatory comparables to K211085.
SonoBlock
K241954 · PAJUNK GmbH Medizintechnologie · Sep 2024
Reach Needle
K240253 · Aerin Medical, Inc. · Mar 2024
Medispine - Spinal Needle, Glospine - Spinal Needle
K212982 · Global Medikit Limited · Jul 2022
BD Quincke Spinal Needle, BD Whitacre Spinal Needle, BD Spinal Introducer Needle
K210978 · Becton, Dickinson and Company · Dec 2021
RELI NRFit Epidural Needles, Phoenix NRFit Epidural Needles, RELI NRFit Spinal Needles, Phoenix NRFit Spinal Needles
K203668 · Myco Medical Supplies, Inc. · Sep 2021
DiscCath Needle Set
K212328 · Disccath, LLC · Sep 2021